---
$id: https://graph.org.ai/products/commodity/51272405
$type: Product
source: UNSPSC
code: "51272405"
title: "Fomocaine"
class: "51272400"
classTitle: "Anaesthetic ethers"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Fomocaine

**UNSPSC Code**: 51272405
**Class**: [Anaesthetic ethers](Anaesthetic ethers.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4XO7A09HQM. European Medicines Agency schedules Fomocaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07779MIG. Fomocaine generally arises in the molecular formula C20H25NO2. The term FOMOCAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, no 10 1978, list 18.) FOMOCAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fomocaine under HS 29349990 and SITC 51579. As of Q4 2014, FOMOCAINE remains the US FDA Preferred Term for this commodity. Fomocaine bears US NLM identifiers UMLS ID C0060629 and NCI Concept Code C65747. SMILES: O1CCN(CCCC2CCC(CC2)COC2CCCCC2)CC1.

